Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Operating Leases (2019 - 2026)

Healthstream has reported Operating Leases over the past 7 years, most recently at $14.7 million for Q4 2025.

  • Quarterly Operating Leases fell 15.44% to $14.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.7 million through Dec 2025, down 15.44% year-over-year, with the annual reading at $14.7 million for FY2025, 15.44% down from the prior year.
  • Operating Leases was $14.7 million for Q4 2025 at Healthstream, down from $15.3 million in the prior quarter.
  • Over five years, Operating Leases peaked at $27.7 million in Q1 2021 and troughed at $14.7 million in Q4 2025.
  • The 5-year median for Operating Leases is $21.4 million (2023), against an average of $21.3 million.
  • Year-over-year, Operating Leases decreased 6.32% in 2021 and then fell 15.44% in 2025.
  • A 5-year view of Operating Leases shows it stood at $26.2 million in 2021, then dropped by 10.91% to $23.3 million in 2022, then fell by 13.18% to $20.2 million in 2023, then fell by 14.23% to $17.4 million in 2024, then fell by 15.44% to $14.7 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Operating Leases are $14.7 million (Q4 2025), $15.3 million (Q3 2025), and $15.9 million (Q2 2025).